Pillstats
Rx only · Tablet, Film Coated · Oral

Brivaracetam

Brands: Briviact · Brivaracetam

7 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US34 NDCs
7 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC—
RxCUI (US)—
US makers7 labelers
Packages63
DEA / ScheduleCV

US acquisition costNADAC · per unit

Average across 18 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$6.92$13.84$20.77$27.69Dec 2025May 2026Jul 2026
$10.819
Latest avg · Jul 22, 2026
-54%
Since Dec 17, 2025
7
Active US suppliers
48%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

21K43K64K85K2025 Q12025 Q22025 Q32025 Q42026 Q1
70K
Rx · 2026 Q1
4.9M
Units dispensed
+4%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it7 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Zydus Lifesciences Limitedunknown15SUPPLYING
Zydus Pharmaceuticals USA Inc.unknown15SUPPLYING
UCB, Inc.unknown11SUPPLYING
Novadoz Pharmaceuticals LLCunknown8SUPPLYING
Aurobindo Pharma Limitedunknown5SUPPLYING
SolarisPharmaCorporationunknown5SUPPLYING
AvKAREunknown4SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Mar 15, 2021
    RECALLRecall (Class II): Briviact (brivaracetam) tablets 50 mg, 60-count bottle, Rx only Manufactured for UCB, Inc. Smyrna, GA 30080, NDC 50474-…

    CGMP Deviations: Intermittent exposure to temperature excursion during storage. — Recalling firm: Cardinal Health Inc. — FL, GA, SC